Dividend
-
-
-
-
-
-
-
Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results
-
-
-
-
-
-
-
Kane Biotech receives FDA clearance for wound cleanser product
-
-
-
-
-
-
-
Kane Biotech Announces Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
Kane Biotech (KNE) reports reorganization update
-
-
-
-
-
-
-
Kane Biotech Announces $3,000,000 Private Placement Offering
-
-
-
-
-
-
-
Kane Biotech Announces Donation of revyve™ Antimicrobial Wound Gel to Ukraine
-
-
-
-
-
-
-
Kane Biotech Announces Distribution Agreement with Qatar Datamation Systems for revyve™ Antimicrobial Wound Gel
-
453,904 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

